About Rosetta Genomics
Rosetta Genomics is a company based in Philadelphia (United States) founded in 2000 was acquired by Genoptix in December 2017.. Rosetta Genomics has raised $4 million across 9 funding rounds from investors including Teva Pharmaceuticals, Prometheus Laboratories and European Union. Rosetta Genomics operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Philadelphia, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4 M (USD)
in 9 rounds
-
Latest Funding Round
-
Investors
Teva Pharmaceuticals
& 14 more
-
Employee Count
Employee Count
-
Acquired by
Genoptix
(Dec 15, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Rosetta Genomics
Rosetta Genomics has successfully raised a total of $4M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Last Round
-
First Round
First Round
(24 Mar 2005)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2017 | Amount | Grant - Rosetta Genomics | Valuation |
investors |
|
| Aug, 2013 | Amount | Grant - Rosetta Genomics | Valuation |
investors |
|
| Feb, 2012 | Amount | Post-IPO - Rosetta Genomics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rosetta Genomics
Rosetta Genomics has secured backing from 15 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Teva Pharmaceuticals, Prometheus Laboratories and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are targeted in Israel and the US.
|
Founded Year | Domain | Location | |
|
Diagnostics and therapeutics for gastrointestinal and personalized medicine are developed.
|
Founded Year | Domain | Location | |
|
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rosetta Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rosetta Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rosetta Genomics Comparisons
Competitors of Rosetta Genomics
Rosetta Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rosetta Genomics
Frequently Asked Questions about Rosetta Genomics
When was Rosetta Genomics founded?
Rosetta Genomics was founded in 2000 and raised its 1st funding round 5 years after it was founded.
Where is Rosetta Genomics located?
Rosetta Genomics is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Is Rosetta Genomics a funded company?
Rosetta Genomics is a funded company, having raised a total of $4M across 9 funding rounds to date. The company's 1st funding round was a Post-IPO of $1.75M, raised on Mar 24, 2005.
What does Rosetta Genomics do?
RosettaGX develops genetic tests for cancer. It offers a variety of proprietary assays that use FISH, miRNA analysis and next-generation sequencing. Its Cancer Origin Test enables physicians to discover the exact source of cancers of unknown origin. OncoGxOne and OnocGxLung use next generation sequencing for genomic profiling solid tumors and lung cancer. Reveal uses advanced miRNA expression analysis to determine necessity of surgery for thyroid cancer. In addition, the company also provides FISH and PCR assays for lung, prostate, bladder, breast and kidney cancers.
Who are the top competitors of Rosetta Genomics?
Rosetta Genomics's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
Who are Rosetta Genomics's investors?
Rosetta Genomics has 15 investors. Key investors include Teva Pharmaceuticals, Prometheus Laboratories, European Union, Kadimastem, and Genoptix.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.